150 related articles for article (PubMed ID: 21158181)
21. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
22. The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
Beesdo K; Hartford J; Russell J; Spann M; Ball S; Wittchen HU
J Anxiety Disord; 2009 Dec; 23(8):1064-71. PubMed ID: 19643572
[TBL] [Abstract][Full Text] [Related]
23. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
[TBL] [Abstract][Full Text] [Related]
24. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
Cowen PJ; Ogilvie AD; Gama J
Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of depression by the general practitioner].
Messer T; Tiltscher C
MMW Fortschr Med; 2013 May; 155(8):43-6; quiz 47-8. PubMed ID: 24437137
[No Abstract] [Full Text] [Related]
26. Somatic symptoms, depression, and antidepressant treatment.
Fava M
J Clin Psychiatry; 2002 Apr; 63(4):305-7. PubMed ID: 12000203
[No Abstract] [Full Text] [Related]
27. Severe and symptomatic hyponatremia following duloxetine treatment.
Müssig K; Mörike K; Häring HU
J Psychopharmacol; 2009 May; 23(3):338-9. PubMed ID: 18562431
[No Abstract] [Full Text] [Related]
28. [The weeping patient].
Wolff-Menzler C; Bandelow B
MMW Fortschr Med; 2010 Sep; 152(38):29-30. PubMed ID: 20957784
[No Abstract] [Full Text] [Related]
29. [Depression: early diagnosis and quality of life].
Fabrégas B
Soins Psychiatr; 2002 Jul; (221):16. PubMed ID: 12162005
[No Abstract] [Full Text] [Related]
30. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
[TBL] [Abstract][Full Text] [Related]
31. [Depression in general practitioner].
Magalon-Bingenheimer K; Magalon D; Zendjidjian X; Boyer L; Griguer Y; Lançon C
Presse Med; 2013 Apr; 42(4 Pt 1):419-28. PubMed ID: 23140855
[TBL] [Abstract][Full Text] [Related]
32. [18 million sick days due to depressive illnesses. New prospects in therapy of depression].
Krankenpfl J; 2003; 41(10-12):226-7. PubMed ID: 14746205
[No Abstract] [Full Text] [Related]
33. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.
Meighen KG
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):121-7. PubMed ID: 17343560
[TBL] [Abstract][Full Text] [Related]
34. [Focus on treatment success of depressed patients. Early and significant pain reduction improves chances for remission].
MMW Fortschr Med; 2010 Mar; 152(9):78-9. PubMed ID: 20384105
[No Abstract] [Full Text] [Related]
35. Safety of electroconvulsive therapy-duloxetine combination.
Eraslan D; Genc Y; Odabasioglu G; Ergun BM; Ozturk O
J ECT; 2011 Sep; 27(3):e51-2. PubMed ID: 21865952
[No Abstract] [Full Text] [Related]
36. Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.
Dunner DL; Wilson M; Fava M; Kornstein S; Munoz R; O'Reardon J; Trivedi M; Wohlreich M
Depress Anxiety; 2008; 25(5):E1-8. PubMed ID: 17621644
[TBL] [Abstract][Full Text] [Related]
37. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
Nelson JC
Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
[TBL] [Abstract][Full Text] [Related]
38. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
Fava M; Wiltse C; Walker D; Brecht S; Chen A; Perahia D
J Affect Disord; 2009 Mar; 113(3):263-71. PubMed ID: 18625521
[TBL] [Abstract][Full Text] [Related]
39. [2: Patient with somatoform manifestations of depression. How to promote insight?].
Zacher A
MMW Fortschr Med; 2003 Jun; 145(26):48-50. PubMed ID: 12916338
[No Abstract] [Full Text] [Related]
40. New hope in the treatment of painful symptoms in depression.
Briley M
Curr Opin Investig Drugs; 2003 Jan; 4(1):42-5. PubMed ID: 12625027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
